Sun Pharmaceutical Industries Ltd. reported the highest ever quarterly revenue in the first three months of fiscal 2022, buoyed to a significant extent by the strong showing on the domestic market which saw over a dozen new launches.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?